1. Home
  2. Labeler Index
  3. Abon Pharmaceuticals, Llc
  4. 42239-001
  5. NDC Package Code: 42239-001-08 Atovaquone

NDC Package 42239-001-08 Atovaquone

Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
42239-001-08
Package Description:
1 BOTTLE in 1 CARTON / 210 mL in 1 BOTTLE
Product Code:
42239-001
Proprietary Name:
Atovaquone
Non-Proprietary Name:
Atovaquone
Substance Name:
Atovaquone
Usage Information:
Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath.
11-Digit NDC Billing Format:
42239000108
NDC to RxNorm Crosswalk:
  • RxCUI: 308429 - atovaquone 750 MG in 5 mL Oral Suspension
  • RxCUI: 308429 - atovaquone 150 MG/ML Oral Suspension
  • RxCUI: 308429 - atovaquone 1500 MG per 10 ML Oral Suspension
  • RxCUI: 308429 - atovaquone 750 MG per 5 ML Oral Suspension
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Abon Pharmaceuticals, Llc
    Dosage Form:
    Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ATOVAQUONE 750 mg/5mL
    • Pharmacologic Class(es):
  • Antimalarial - [EPC] (Established Pharmacologic Class)
  • Antiprotozoal - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA214272
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    11-14-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 42239-001-08?

    The NDC Packaged Code 42239-001-08 is assigned to a package of 1 bottle in 1 carton / 210 ml in 1 bottle of Atovaquone, a human prescription drug labeled by Abon Pharmaceuticals, Llc. The product's dosage form is suspension and is administered via oral form.

    Is NDC 42239-001 included in the NDC Directory?

    Yes, Atovaquone with product code 42239-001 is active and included in the NDC Directory. The product was first marketed by Abon Pharmaceuticals, Llc on November 14, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 42239-001-08?

    The 11-digit format is 42239000108. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-242239-001-085-4-242239-0001-08